Superbugs & Superdrugs USA 2018

Date: 12-Nov-18 to 13-Nov-18
Location: Renaissance Woodbridge Hotel / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

Building on the success of last year, SMi proudly presents its 3rd annual Superbugs & Superdrugs USA conference, taking place in New Jersey, USA in November 12th & 13th, 2018.

This year's event is set to address the issue of antibacterial resistance, which is becoming increasingly prevalent in the world of modern medicine. Difficult-to-treat pathogens creating issues within clinical environments need to be addressed with novel treatments and the development of mechanisms which circumvent current therapeutic barriers.

To address the ever-growing need of informative and thought-provoking discussion, Superbugs & Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers within the field, as well as the opportunity to network with decision makers from the industry – from research, to commercial providers and regulatory bodies.

2018 Event Highlights:

• Learn about pathogen-focused drug development
• Discover the best methods to overcome bacterial resistance though novel modes of action
• Discuss the state of developments within the anti-fungal space
• Develop an understanding of funding opportunities which support antibacterial research
• Gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used

In addition, two interactive half-day workshops will be running on 14th November:

Workshop A: “Rapid diagnostics for drug resistance: Are we there yet?”, led by David Perlin, Executive Director & Professor, Public Health Research Institute, Rutgers University.

Workshop B: “Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics”, hosted by Adam Woodrow, CCO, Parateck, and David Findlay, Managing Director, Morton Findlay and Associates Ltd.

Register by:
June 29th to save $300
September 28th to save $100

To book your place and download the brochure, please visit:


Tina Guina, Program Officer, Drug Development Section, NIAID/NIH, Mark Albrecht, Project Officer, HHS/ASPR/BARDA, Antonio DiGiandomenico, Principal Scientist, MedImmune, Andrew Tomaras, VP & Director of Microbiology, Bacterioscan, Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx, Ian Friedland, Clinical Consultant, ex-CMO, Achaogen

Go to event website